Microbicide offers no protection against HIV infection

  title={Microbicide offers no protection against HIV infection},
  author={B. Roehr},
  journal={BMJ : British Medical Journal},
  • B. Roehr
  • Published 2009
  • Medicine
  • BMJ : British Medical Journal
  • There has been another setback in efforts to develop a microbicide to protect women against HIV infection during vaginal sex. Results of a large clinical trial of PRO 2000, released on 14 December, showed that although the product was safe, it was not effective against infection. The large (9385 women) double blind, placebo controlled trial (called MDP 301) was conducted by the Microbicides Development Programme—a broad international collaboration—in South Africa, Tanzania, Uganda, and Zambia… CONTINUE READING
    14 Citations

    Topics from this paper

    Development of Preclinical Biomarkers Predictive of Safety of Vaginal Microbicides for the Prevention of HIV
    • Highly Influenced
    • PDF
    In Vitro Evaluation of Viability, Integrity, and Inflammation in Genital Epithelia upon Exposure to Pharmaceutical Excipients and Candidate Microbicides
    • 61
    • PDF
    Preclinical safety assessment of Griffithsin-based vaginal microbicides.
    • 1
    • PDF
    3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin Exhibits Potent and Broad Anti-HIV-1 Activity: a Potential Microbicide for Preventing Sexual Transmission of HIV-1
    • Lin Li, L. He, +7 authors Shuwen Liu
    • Biology, Medicine
    • Antimicrobial Agents and Chemotherapy
    • 2010
    • 26
    • PDF
    A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea])
    • 11
    A Novel Strategy for Inducing Enhanced Mucosal HIV-1 Antibody Responses in an Anti-Inflammatory Environment
    • 15
    • PDF